Theravance Bio: Q1 Earnings Snapshot

GEORGE TOWN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Tuesday reported a loss of $79.7 million in its first quarter.

On a per-share basis, the George Town, Cayman Islands-based company said it had a loss of $1.24.

The results did not meet Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $1.05 per share.

The biopharmaceutical company posted revenue of $14.3 million in the period, also falling short of Street forecasts. Five analysts surveyed by Zacks expected $17.5 million.

Theravance Bio shares have climbed 12% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $19.88, a decrease of 25% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on TBPH at